Western blotting inaccuracies with unverified antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS)

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Gilda, Jennifer E ^a   Ghosh, Rajeshwary ^a   Cheah, Jenice X ^a   West, Toni M ^b   Bodine, Sue C ^a,b   Gomes, Aldrin V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA ACTIN ANTIBODY; BUFFER; INTERFERON STIMULATED GENE 15 PROTEIN; PROTEIN ANTIBODY; PSMA6 ANTIBODY; UBIQUITIN ANTIBODY; UNCLASSIFIED DRUG; CYTOKINE; ISG15 PROTEIN, RAT; UBIQUITIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; DIMERIZATION; GENE; HEART; HEART HOMOGENATE; ISG15 GENE; LIMIT OF QUANTITATION; LIVER; LIVER HOMOGENATE; MALE; MEDICAL RESEARCH; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN MODIFICATION; PROTEIN PROCESSING; PUBLICATION; RAT; REPRODUCIBILITY; STANDARD; UBIQUITINATION; VALIDATION PROCESS; WESTERN BLOTTING; WESTERN BLOTTING MINIMAL REPORTING STANDARD; ANIMAL; CARDIAC MUSCLE; CELL LINE; FISCHER 344 RAT; IMMUNOLOGY; METABOLISM; PROCEDURES; VALIDATION STUDY;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELL LINE; CYTOKINES; MALE; MICE; MYOCARDIUM; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; UBIQUITIN; UBIQUITINS;

EID: 84942446977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135392     Document Type: Article

References (37)

1. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America. 1979; 76(9):4350-4. Epub 1979/09/01. PMID: 388439; PubMed Central PMCID: PMC411572.
2. Ghosh R, Gilda JE, Gomes AV. The necessity of and strategies for improving confidence in the accuracy of western blots. Expert review of proteomics. 2014:1-12. Epub 2014/07/26. doi: 10.1586/14789450.2014.939635 PMID: 25059473.
3. Yu W, Hill WG. Lack of specificity shown by P2Y6 receptor antibodies. Naunyn-Schmiedeberg's archives of pharmacology. 2013; 386(10):885-91. Epub 2013/06/25. doi: 10.1007/s00210-013-0894-8 PMID: 23793102; PubMed Central PMCID: PMC3772977.
4. Petry FR, Pelletier J, Bretteville A, Morin F, Calon F, Hebert SS, et al. Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. PloS one. 2014; 9(5): e94251. Epub 2014/05/03. doi: 10.1371/journal.pone.0094251 PMID: 24788298; PubMed Central PMCID: PMC4008431.
5. Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM. Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension. 2013; 61(1):253-8. Epub 2012/11/15. doi: 10.1161/HYPERTENSIONAHA.112.203679 PMID: 23150519; PubMed Central PMCID: PMC3523722.
6. Cernecka H, Ochodnicky P, Lamers WH, Michel MC. Specificity evaluation of antibodies against human beta3-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology. 2012; 385(9):875-82. Epub 2012/06/13. doi: 10.1007/s00210-012-0767-6 PMID: 22688595.
7. Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM. Six commercially available angiotensin II AT1 receptor antibodies are non-specific. Cellular and molecular neurobiology. 2012; 32(8):1353-65. Epub 2012/07/31. doi: 10.1007/s10571-012-9862-y PMID: 22843099; PubMed Central PMCID: PMC3508356.
8. Beermann S, Seifert R, Neumann D. Commercially available antibodies against human and murine histamine H(4)-receptor lack specificity. Naunyn-Schmiedeberg's archives of pharmacology. 2012; 385 (2):125-35. Epub 2011/11/11. doi: 10.1007/s00210-011-0700-4 PMID: 22071576.
9. Gibson JA, Hahn HP, Shahsafaei A, Odze RD. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. The American journal of surgical pathology. 2011; 35(5):742-9. Epub 2011/04/15. PMID: 21490447.
10. Marchalant Y, Brownjohn PW, Bonnet A, Kleffmann T, Ashton JC. Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2014; 62(6):395-404. Epub 2014/03/29. doi: 10.1369/0022155414530995 PMID: 24670796.
11. Bernstone L, van Wilgenburg B, James W. Several commercially available anti-CCR5 monoclonal antibodies lack specificity and should be used with caution. Hybridoma (Larchmt). 2012; 31(1):7-19. Epub 2012/02/10. doi: 10.1089/hyb.2010.0092 PMID: 22316480.
12. Egelhofer TA, Minoda A, Klugman S, Lee K, Kolasinska-Zwierz P, Alekseyenko AA, et al. An assessment of histone-modification antibody quality. Nature structural & molecular biology. 2011; 18(1):91-3. Epub 2010/12/07. doi: 10.1038/nsmb.1972 PMID: 21131980; PubMed Central PMCID: PMC3017233.
13. Berglund L, Bjorling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Molecular & cellular proteomics: MCP. 2008; 7(10):2019-27. Epub 2008/08/02. doi: 10.1074/mcp.R800013-MCP200 PMID: 18669619.
14. Ferrara F, D'Angelo S, Gaiotto T, Naranjo L, Tian H, Graslund S, et al. Recombinant renewable polyclonal antibodies. mAbs. 2015; 7(1):32-41. Epub 2014/12/23. doi: 10.4161/19420862.2015.989047 PMID: 25530082.
15. Bradbury A, Pluckthun A. Reproducibility: Standardize antibodies used in research. Nature. 2015; 518 (7537):27-9. Epub 2015/02/06. doi: 10.1038/518027a PMID: 25652980.
16. Dewey S, Lai X, Witzmann FA, Sohal M, Gomes AV. Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy. Journal of proteome research. 2013; 12(9):3920-33. Epub 2013/07/16. doi: 10.1021/pr4004739 PMID: 23848590.
17. Bederman IR, Lai N, Shuster J, Henderson L, Ewart S, Cabrera ME. Chronic hindlimb suspension unloading markedly decreases turnover rates of skeletal and cardiac muscle proteins and adipose tissue triglycerides. J Appl Physiol (1985). 2015:jap 00004 2014. Epub 2015/05/02. doi: 10.1152/japplphysiol.00004.2014 PMID: 25930021.
18. Moffitt JA, Henry MK, Welliver KC, Jepson AJ, Garnett ER. Hindlimb unloading results in increased predisposition to cardiac arrhythmias and alters left ventricular connexin 43 expression. American journal of physiology Regulatory, integrative and comparative physiology. 2013; 304(5):R362-73. Epub 2013/01/11. doi: 10.1152/ajpregu.00391.2012 PMID: 23302960; PubMed Central PMCID: PMC4459920.
19. Zhang D, Zhang DE. Interferon-stimulated gene 15 and the protein ISGylation system. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2011; 31(1):119-30. Epub 2010/12/31. doi: 10.1089/jir.2010.0110 PMID: 21190487; PubMed Central PMCID: PMC3021351.
20. Kline WO, Panaro FJ, Yang H, Bodine SC. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol (1985). 2007; 102(2):740-7. Epub 2006/10/28. doi: 10.1152/japplphysiol.00873.2006 PMID: 17068216.
21. Lopitz-Otsoa F, Rodriguez-Suarez E, Aillet F, Casado-Vela J, Lang V, Matthiesen R, et al. Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs). Journal of proteomics. 2012; 75(10):2998-3014. Epub 2011/12/20. doi: 10.1016/j.jprot.2011.12.001 PMID: 22178446.
22. Gilda JE, Gomes AV. Stain-Free total protein staining is a superior loading control to beta-actin for Western blots. Analytical biochemistry. 2013; 440(2):186-8. Epub 2013/06/12. doi: 10.1016/j.ab.2013.05.027 PMID: 23747530; PubMed Central PMCID: PMC3809032.
23. Gilda JE, Gomes AV. Western blotting using in-gel protein labeling as a normalization control: stainfree technology. Methods Mol Biol. 2015; 1295:381-91. Epub 2015/03/31. doi: 10.1007/978-1-4939-2550-6-27 PMID: 25820735.
24. Taylor SC, Berkelman T, Yadav G, Hammond M. A defined methodology for reliable quantification of Western blot data. Molecular biotechnology. 2013; 55(3):217-26. Epub 2013/05/28. doi: 10.1007/s12033-013-9672-6 PMID: 23709336; PubMed Central PMCID: PMC3840294.
25. Hjerpe R, Aillet F, Lopitz-Otsoa F, Lang V, England P, Rodriguez MS. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO reports. 2009; 10(11):1250-8. Epub 2009/10/03. doi: 10.1038/embor.2009.192 PMID: 19798103; PubMed Central PMCID: PMC2775171.
26. Liu Z, Zhang WP, Xing Q, Ren X, Liu M, Tang C. Noncovalent dimerization of ubiquitin. Angew Chem Int Ed Engl. 2012; 51(2):469-72. Epub 2011/11/24. doi: 10.1002/anie.201106190 PMID: 22109817; PubMed Central PMCID: PMC3303887.
27. Le Grand JN, Chakrama FZ, Seguin-Py S, Fraichard A, Delage-Mourroux R, Jouvenot M, et al. GABARAPL1 antibodies: target one protein, get one free! Autophagy. 2011; 7(11):1302-7. Epub 2011/08/25. doi: 10.4161/auto.7.11.16723 PMID: 21862879.
28. Marx V. Finding the right antibody for the job. Nat Meth. 2013; 10(8):703-7. doi: 10.1038/nmeth.2570
29. Vigelso A, Dybboe R, Hansen CN, Dela F, Helge JW, Guadalupe Grau A. GAPDH and beta-actin protein decreases with aging, making Stain-Free technology a superior loading control in Western blotting of human skeletal muscle. J Appl Physiol (1985). 2015; 118(3):386-94. Epub 2014/11/28. doi: 10.1152/japplphysiol.00840.2014 PMID: 25429098.
30. Murphy RM, Lamb GD. Important considerations for protein analyses using antibody based techniques: down-sizing Western blotting up-sizes outcomes. The Journal of physiology. 2013; 591(Pt 23):5823-31. Epub 2013/10/16. doi: 10.1113/jphysiol.2013.263251 PMID: 24127618; PubMed Central PMCID: PMC3872754.
31. Mollica JP, Oakhill JS, Lamb GD, Murphy RM. Are genuine changes in protein expression being overlooked? Reassessing Western blotting. Analytical biochemistry. 2009; 386(2):270-5. Epub 2009/01/24. doi: 10.1016/j.ab.2008.12.029 PMID: 19161968.
32. Eaton SL, Roche SL, Llavero Hurtado M, Oldknow KJ, Farquharson C, Gillingwater TH, et al. Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PloS one. 2013; 8(8):e72457. Epub 2013/09/12. doi: 10.1371/journal.pone.0072457 PMID: 24023619; PubMed Central PMCID: PMC3758299.
33. Dittmer A, Dittmer J. Beta-actin is not a reliable loading control in Western blot analysis. Electrophoresis. 2006; 27(14):2844-5. Epub 2006/05/12. doi: 10.1002/elps.200500785 PMID: 16688701.
34. Gassmann M, Grenacher B, Rohde B, Vogel J. Quantifying Western blots: pitfalls of densitometry. Electrophoresis. 2009; 30(11):1845-55. Epub 2009/06/12. doi: 10.1002/elps.200800720 PMID: 19517440.
35. Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. Journal of neuroscience methods. 2008; 172(2):250-4. Epub 2008/06/24. doi: 10.1016/j.jneumeth.2008.05.003 PMID: 18571732; PubMed Central PMCID: PMC2567873.
36. Manning CF, Bundros AM, Trimmer JS. Benefits and pitfalls of secondary antibodies: why choosing the right secondary is of primary importance. PloS one. 2012; 7(6):e38313. Epub 2012/06/08. doi: 10.1371/journal.pone.0038313 PMID: 22675541; PubMed Central PMCID: PMC3365890.
37. Kruchinina NG, Gresshoff PM. Detergent affects silver sequencing. BioTechniques. 1994; 17(2):280-2. Epub 1994/08/01. PMID: 7980926.